Minimally Invasive Approaches to the Surgical Management of Fibroids

Abstract

Uterine fibroids, as the most common benign neoplasm of the female reproductive tract, can significantly impact a woman's quality of life through abnormal uterine bleeding, infertility, and bulk symptoms. When medical therapy for symptomatic fibroids fails, surgery is the recommended treatment. While a hysterectomy through laparotomy was historically the first-line surgical approach for fibroids, multiple minimally invasive and uterine-sparing techniques are now available. An evidence-based literature review of the following minimally invasive approaches is detailed in this article: hysteroscopic myomectomy, laparoscopic and robotically assisted myomectomy, laparoscopic and robotically assisted hysterectomy, and ultrasound-guided radiofrequency ablation. For each approach, this review discusses the indications, patient selection, adjunct preoperative treatment modalities, instrumentation, techniques, and pertinent intraoperative considerations such as fluid management, interventions to reduce blood loss, antiadhesion barriers, and tissue extraction. Perioperative benefits, long-term outcomes including recurrence and fertility, and comparisons of outcomes among the various approaches are outlined as well. With continued technological advancements and surgical innovations, minimally invasive techniques will become the mainstay of surgical management for symptomatic fibroids to provide high-quality patient-centered care.

Keywords

uterine fibroids - minimally invasive - myomectomy - hysteroscopy - hysterectomy - radiofrequency ablation

Funding

There was no specific source of funding for this review article.

• References

• 1 Yoshino O, Hayashi T, Osuga Y. , et al. Decreased pregnancy rate is linked to abnormal uterine peristalsis caused by intramural fibroids. Hum Reprod 2010; 25 (10) 2475-2479
• 2 Baird DD, Dunson DB, Hill MC, Cousins D, Schectman JM. High cumulative incidence of uterine leiomyoma in black and white women: ultrasound evidence. Am J Obstet Gynecol 2003; 188 (01) 100-107
• 3 Fernandez H. Uterine fibroids [in French]. Rev Prat 2014; 64 (04) 540-544
• 4 Laughlin SK, Baird DD, Savitz DA, Herring AH, Hartmann KE. Prevalence of uterine leiomyomas in the first trimester of pregnancy: an ultrasound-screening study. Obstet Gynecol 2009; 113 (03) 630-635
• 5 Donnez J, Dolmans MM. Uterine fibroid management: from the present to the future. Hum Reprod Update 2016; 22 (06) 665-686
• 6 Flyckt R, Coyne K, Falcone T. Minimally invasive myomectomy. Clin Obstet Gynecol 2017; 60 (02) 252-272
• 7 Munro MG, Critchley HO, Broder MS, Fraser IS. ; FIGO Working Group on Menstrual Disorders. FIGO classification system (PALM-COEIN) for causes of abnormal uterine bleeding in nongravid women of reproductive age. Int J Gynaecol Obstet 2011; 113 (01) 3-13
• 8 Cardozo ER, Clark AD, Banks NK, Henne MB, Stegmann BJ, Segars JH. The estimated annual cost of uterine leiomyomata in the United States. Am J Obstet Gynecol 2012; 206 (03) 211.e1-211.e9
• 9 Merrill RM, Layman AB, Oderda G, Asche C. Risk estimates of hysterectomy and selected conditions commonly treated with hysterectomy. Ann Epidemiol 2008; 18 (03) 253-260
• 10 Lewis EI, Gargiulo AR. The role of hysteroscopic and robot-assisted laparoscopic myomectomy in the setting of infertility. Clin Obstet Gynecol 2016; 59 (01) 53-65
• 11 Lee BB, Yu SP. Radiofrequency ablation of uterine fibroids: a review. Curr Obstet Gynecol Rep 2016; 5 (04) 318-324
• 12 Doherty L, Mutlu L, Sinclair D, Taylor H. Uterine fibroids: clinical manifestations and contemporary management. Reprod Sci 2014; 21 (09) 1067-1092
• 13 Thubert T, Foulot H, Vinchant M. , et al. Surgical treatment: myomectomy and hysterectomy; endoscopy: a major advancement. Best Pract Res Clin Obstet Gynaecol 2016; 34: 104-121
• 14 Committee on Practice Bulletins—Gynecology. Practice bulletin no. 128: diagnosis of abnormal uterine bleeding in reproductive-aged women. Obstet Gynecol 2012; 120 (01) 197-206
• 15 Vathanan V, Armar NA. A comparative observational study of the use of saline uterine hydrosonography for the diagnosis and assessment of uterine cavity lesions in women. Int J Reprod Med 2016; 2016: 9317194
• 16 Seshadri S, El-Toukhy T, Douiri A, Jayaprakasan K, Khalaf Y. Diagnostic accuracy of saline infusion sonography in the evaluation of uterine cavity abnormalities prior to assisted reproductive techniques: a systematic review and meta-analyses. Hum Reprod Update 2015; 21 (02) 262-274
• 17 Emanuel MH. Hysteroscopy and the treatment of uterine fibroids. Best Pract Res Clin Obstet Gynaecol 2015; 29 (07) 920-929
• 18 Barral M, Place V, Dautry R. , et al. Magnetic resonance imaging features of uterine sarcoma and mimickers. Abdom Radiol (NY) 2017; 42 (06) 1762-1772
• 19 Lumsden MA, Hamoodi I, Gupta J, Hickey M. Fibroids: diagnosis and management. BMJ 2015; 351: h4887
• 20 Maciel C, Tang YZ, Sahdev A, Madureira AM, Vilares Morgado P. Preprocedural MRI and MRA in planning fibroid embolization. Diagn Interv Radiol 2017; 23 (02) 163-171
• 21 Stewart EA. Clinical practice. Uterine fibroids. N Engl J Med 2015; 372 (17) 1646-1655
• 22 Wu TI, Yen TC, Lai CH. Clinical presentation and diagnosis of uterine sarcoma, including imaging. Best Pract Res Clin Obstet Gynaecol 2011; 25 (06) 681-689
• 23 Sato K, Yuasa N, Fujita M, Fukushima Y. Clinical application of diffusion-weighted imaging for preoperative differentiation between uterine leiomyoma and leiomyosarcoma. Am J Obstet Gynecol 2014; 210 (04) 368.e1-368.e8
• 24 Nagai T, Takai Y, Akahori T. , et al. Novel uterine sarcoma preoperative diagnosis score predicts the need for surgery in patients presenting with a uterine mass. Springerplus 2014; 3: 678-1801
• 25 Nagai T, Takai Y, Akahori T. , et al. Highly improved accuracy of the revised PREoperative sarcoma score (rPRESS) in the decision of performing surgery for patients presenting with a uterine mass. Springerplus 2015; 4: 520-015
• 26 Santos P, Cunha TM. Uterine sarcomas: clinical presentation and MRI features. Diagn Interv Radiol 2015; 21 (01) 4-9
• 27 Schwartz LB, Zawin M, Carcangiu ML, Lange R, McCarthy S. Does pelvic magnetic resonance imaging differentiate among the histologic subtypes of uterine leiomyomata?. Fertil Steril 1998; 70 (03) 580-587
• 28 Goto A, Takeuchi S, Sugimura K, Maruo T. Usefulness of Gd-DTPA contrast-enhanced dynamic MRI and serum determination of LDH and its isozymes in the differential diagnosis of leiomyosarcoma from degenerated leiomyoma of the uterus. Int J Gynecol Cancer 2002; 12 (04) 354-361
• 29 Alkatout I, Mettler L, Günther V. , et al. Safety and economical innovations regarding surgical treatment of fibroids. Minim Invasive Ther Allied Technol 2016; 25 (06) 301-313
• 30 Keltz MD, Greene AD, Morrissey MB, Vega M, Moshier E. Sonohysterographic predictors of successful hysteroscopic myomectomies. JSLS 2015; 19 (01) 00105
• 31 American Association of Gynecologic Laparoscopists (AAGL): Advancing Minimally Invasive Gynecology Worldwide. AAGL practice report: practice guidelines for the diagnosis and management of submucous leiomyomas. J Minim Invasive Gynecol 2012; 19 (02) 152-171
• 32 Chittawar PB, Kamath MS. Review of nonsurgical/minimally invasive treatments and open myomectomy for uterine fibroids. Curr Opin Obstet Gynecol 2015; 27 (06) 391-397
• 33 Camanni M, Bonino L, Delpiano EM, Ferrero B, Migliaretti G, Deltetto F. Hysteroscopic management of large symptomatic submucous uterine myomas. J Minim Invasive Gynecol 2010; 17 (01) 59-65
• 34 Donnez J, Jadoul P. What are the implications of myomas on fertility? A need for a debate?. Hum Reprod 2002; 17 (06) 1424-1430
• 35 Mazzon I, Favilli A, Grasso M. , et al. Predicting success of single step hysteroscopic myomectomy: a single centre large cohort study of single myomas. Int J Surg 2015; 22: 10-14
• 36 Di Spiezio Sardo A, Mazzon I, Bramante S. , et al. Hysteroscopic myomectomy: a comprehensive review of surgical techniques. Hum Reprod Update 2008; 14 (02) 101-119
• 37 Yang JH, Lin BL. Changes in myometrial thickness during hysteroscopic resection of deeply invasive submucous myomas. J Am Assoc Gynecol Laparosc 2001; 8 (04) 501-505
• 38 Polyzos NP, Zavos A, Valachis A. , et al. Misoprostol prior to hysteroscopy in premenopausal and post-menopausal women. A systematic review and meta-analysis. Hum Reprod Update 2012; 18 (04) 393-404
• 39 Selk A, Kroft J. Misoprostol in operative hysteroscopy: a systematic review and meta-analysis. Obstet Gynecol 2011; 118 (04) 941-949
• 40 Gkrozou F, Koliopoulos G, Vrekoussis T. , et al. A systematic review and meta-analysis of randomized studies comparing misoprostol versus placebo for cervical ripening prior to hysteroscopy. Eur J Obstet Gynecol Reprod Biol 2011; 158 (01) 17-23
• 41 Song T, Kim MK, Kim ML, Jung YW, Yoon BS, Seong SJ. Effectiveness of different routes of misoprostol administration before operative hysteroscopy: a randomized, controlled trial. Fertil Steril 2014; 102 (02) 519-524
• 42 Cooper NA, Smith P, Khan KS, Clark TJ. Does cervical preparation before outpatient hysteroscopy reduce women's pain experience? A systematic review. BJOG 2011; 118 (11) 1292-1301
• 43 Darwish AM, Ahmad AM, Mohammad AM. Cervical priming prior to operative hysteroscopy: a randomized comparison of laminaria versus misoprostol. Hum Reprod 2004; 19 (10) 2391-2394
• 44 Lin YH, Hwang JL, Seow KM, Huang LW, Chen HJ, Hsieh BC. Laminaria tent vs misoprostol for cervical priming before hysteroscopy: Randomized study. J Minim Invasive Gynecol 2009; 16 (06) 708-712
• 45 Oppegaard KS, Lieng M, Berg A, Istre O, Qvigstad E, Nesheim BI. A combination of misoprostol and estradiol for preoperative cervical ripening in postmenopausal women: a randomised controlled trial. BJOG 2010; 117 (01) 53-61
• 46 Lethaby A, Vollenhoven B, Sowter M. Pre-operative GnRH analogue therapy before hysterectomy or myomectomy for uterine fibroids. Cochrane Database Syst Rev 2001; (02) CD000547
• 47 Kamath MS, Kalampokas EE, Kalampokas TE. Use of GnRH analogues pre-operatively for hysteroscopic resection of submucous fibroids: a systematic review and meta-analysis. Eur J Obstet Gynecol Reprod Biol 2014; 177: 11-18
• 48 Donnez J, Tatarchuk TF, Bouchard P. , et al; PEARL I Study Group. Ulipristal acetate versus placebo for fibroid treatment before surgery. N Engl J Med 2012; 366 (05) 409-420
• 49 Bizzarri N, Ghirardi V, Remorgida V, Venturini PL, Ferrero S. Three-month treatment with triptorelin, letrozole and ulipristal acetate before hysteroscopic resection of uterine myomas: prospective comparative pilot study. Eur J Obstet Gynecol Reprod Biol 2015; 192: 22-26
• 50 Ferrero S, Racca A, Tafi E, Alessandri F, Venturini PL, Leone Roberti Maggiore U. Ulipristal acetate before high complexity hysteroscopic myomectomy: a retrospective comparative study. J Minim Invasive Gynecol 2016; 23 (03) 390-395
• 51 Laughlin-Tommaso SK. Alternatives to hysterectomy: management of uterine fibroids. Obstet Gynecol Clin North Am 2016; 43 (03) 397-413
• 52 Zayed M, Fouda UM, Zayed SM, Elsetohy KA, Hashem AT. Hysteroscopic myomectomy of large submucous myomas in a 1-step procedure using multiple slicing sessions technique. J Minim Invasive Gynecol 2015; 22 (07) 1196-1202
• 53 Mazzon I, Favilli A, Grasso M, Morricone D, Di Renzo GC, Gerli S. Is ‘cold loop’ hysteroscopic myomectomy a better option for reproduction in women with diffuse uterine leiomyomatosis? A case report of successful repeated pregnancies. J Obstet Gynaecol Res 2015; 41 (03) 474-477
• 54 Mazzon I, Favilli A, Grasso M, Horvath S, Di Renzo GC, Gerli S. Is cold loop hysteroscopic myomectomy a safe and effective technique for the treatment of submucous myomas with intramural development? A series of 1434 surgical procedures. J Minim Invasive Gynecol 2015; 22 (05) 792-798
• 55 Emanuel MH, Hart A, Wamsteker K, Lammes F. An analysis of fluid loss during transcervical resection of submucous myomas. Fertil Steril 1997; 68 (05) 881-886
• 56 Corson SL, Brooks PG, Serden SP, Batzer FR, Gocial B. Effects of vasopressin administration during hysteroscopic surgery. J Reprod Med 1994; 39 (06) 419-423
• 57 Phillips DR, Nathanson HG, Milim SJ, Haselkorn JS, Khapra A, Ross PL. The effect of dilute vasopressin solution on blood loss during operative hysteroscopy: a randomized controlled trial. Obstet Gynecol 1996; 88 (05) 761-766
• 58 Wong AS, Cheung CW, Yeung SW, Fan HL, Leung TY, Sahota DS. Transcervical intralesional vasopressin injection compared with placebo in hysteroscopic myomectomy: a randomized controlled trial. Obstet Gynecol 2014; 124 (05) 897-903
• 59 Munro MG, Storz K, Abbott JA. , et al; AAGL Advancing Minimally Invasive Gynecology Worldwide. AAGL practice report: practice guidelines for the management of hysteroscopic distending media: (Replaces hysteroscopic fluid monitoring guidelines. J Am Assoc Gynecol Laparosc. 2000;7:167–168.). J Minim Invasive Gynecol 2013; 20 (02) 137-148
• 60 Mais V, Cirronis MG, Peiretti M, Ferrucci G, Cossu E, Melis GB. Efficacy of auto-crosslinked hyaluronan gel for adhesion prevention in laparoscopy and hysteroscopy: a systematic review and meta-analysis of randomized controlled trials. Eur J Obstet Gynecol Reprod Biol 2012; 160 (01) 1-5
• 61 Bosteels J, Weyers S, Mol BW, D'Hooghe T. Anti-adhesion barrier gels following operative hysteroscopy for treating female infertility: a systematic review and meta-analysis. Gynecol Surg 2014; 11: 113-127
• 62 Vercellini P, Zàina B, Yaylayan L, Pisacreta A, De Giorgi O, Crosignani PG. Hysteroscopic myomectomy: long-term effects on menstrual pattern and fertility. Obstet Gynecol 1999; 94 (03) 341-347
• 63 Emanuel MH, Wamsteker K, Hart AA, Metz G, Lammes FB. Long-term results of hysteroscopic myomectomy for abnormal uterine bleeding. Obstet Gynecol 1999; 93 (5, Pt 1): 743-748
• 64 Polena V, Mergui JL, Perrot N, Poncelet C, Barranger E, Uzan S. Long-term results of hysteroscopic myomectomy in 235 patients. Eur J Obstet Gynecol Reprod Biol 2007; 130 (02) 232-237
• 65 Hart R, Molnár BG, Magos A. Long term follow up of hysteroscopic myomectomy assessed by survival analysis. Br J Obstet Gynaecol 1999; 106 (07) 700-705
• 66 Touboul C, Fernandez H, Deffieux X, Berry R, Frydman R, Gervaise A. Uterine synechiae after bipolar hysteroscopic resection of submucosal myomas in patients with infertility. Fertil Steril 2009; 92 (05) 1690-1693
• 67 Taskin O, Sadik S, Onoglu A. , et al. Role of endometrial suppression on the frequency of intrauterine adhesions after resectoscopic surgery. J Am Assoc Gynecol Laparosc 2000; 7 (03) 351-354
• 68 Mazzon I, Favilli A, Cocco P. , et al. Does cold loop hysteroscopic myomectomy reduce intrauterine adhesions? A retrospective study. Fertil Steril 2014; 101 (01) 294-298.e3
• 69 Casini ML, Rossi F, Agostini R, Unfer V. Effects of the position of fibroids on fertility. Gynecol Endocrinol 2006; 22 (02) 106-109
• 70 Roy KK, Baruah J, Sharma JB, Kumar S, Kachawa G, Singh N. Reproductive outcome following hysteroscopic adhesiolysis in patients with infertility due to Asherman's syndrome. Arch Gynecol Obstet 2010; 281 (02) 355-361
• 71 Pritts EA, Parker WH, Olive DL. Fibroids and infertility: an updated systematic review of the evidence. Fertil Steril 2009; 91 (04) 1215-1223
• 72 Fernandez H, Sefrioui O, Virelizier C, Gervaise A, Gomel V, Frydman R. Hysteroscopic resection of submucosal myomas in patients with infertility. Hum Reprod 2001; 16 (07) 1489-1492
• 73 Bosteels J, Kasius J, Weyers S, Broekmans FJ, Mol BW, D'Hooghe TM. Hysteroscopy for treating subfertility associated with suspected major uterine cavity abnormalities. Cochrane Database Syst Rev 2015; (02) CD009461
• 74 Emanuel MH, Wamsteker K. The intra uterine morcellator: a new hysteroscopic operating technique to remove intrauterine polyps and myomas. J Minim Invasive Gynecol 2005; 12 (01) 62-66
• 75 Scheiber MD, Chen SH. A prospective multicenter registry of patients undergoing hysteroscopic morcellation of uterine polyps and myomas. J Gynecol Surg 2016; 32 (06) 318-323
• 76 Arnold A, Ketheeswaran A, Bhatti M, Nesbitt-Hawes E, Abbott J. A prospective analysis of hysteroscopic morcellation in the management of intrauterine pathologies. J Minim Invasive Gynecol 2016; 23 (03) 435-441
• 77 Betjes HE, Hanstede MM, Emanuel MH, Stewart EA. Hysteroscopic myomectomy and case volume hysteroscopic myomectomy performed by high- and low-volume surgeons. J Reprod Med 2009; 54 (07) 425-428
• 78 Rubino RJ, Lukes AS. Twelve-month outcomes for patients undergoing hysteroscopic morcellation of uterine polyps and myomas in an office or ambulatory surgical center. J Minim Invasive Gynecol 2015; 22 (02) 285-290
• 79 Haber K, Hawkins E, Levie M, Chudnoff S. Hysteroscopic morcellation: review of the manufacturer and user facility device experience (MAUDE) database. J Minim Invasive Gynecol 2015; 22 (01) 110-114
• 80 Hamerlynck TW, Dietz V, Schoot BC. Clinical implementation of the hysteroscopic morcellator for removal of intrauterine myomas and polyps. A retrospective descriptive study. Gynecol Surg 2011; 8 (02) 193-196
• 81 Smith PP, Middleton LJ, Connor M, Clark TJ. Hysteroscopic morcellation compared with electrical resection of endometrial polyps: a randomized controlled trial. Obstet Gynecol 2014; 123 (04) 745-751
• 82 van Dongen H, Emanuel MH, Wolterbeek R, Trimbos JB, Jansen FW. Hysteroscopic morcellator for removal of intrauterine polyps and myomas: a randomized controlled pilot study among residents in training. J Minim Invasive Gynecol 2008; 15 (04) 466-471
• 83 Garcia AL, Brill AI. Initial experience with a novel bipolar hysteroscopic tissue removal system: A pilot study using the Symphion(R) system to perform office polypectomy and myomectomy. J Minim Invasive Gynecol 2015; 22 (6S): S114-S115
• 84 Wang H, Zhao J, Li X. , et al. The indication and curative effect of hysteroscopic and laparoscopic myomectomy for type II submucous myomas. BMC Surg 2016; 16: 9-016
• 85 Chen CC, Falcone T. Robotic gynecologic surgery: past, present, and future. Clin Obstet Gynecol 2009; 52 (03) 335-343
• 86 Prentice A, Taylor A, Sharma MA, Magos A. Laparoscopic versus open myomectomy for uterine fibroids (protocol). Cochrane Database Syst Rev 2004; 1: CD004638
• 87 Lee J, Spies J. Management options for uterine fibroids. In: Geschwind J, Dake M. , eds. Abrams' Angiography: Interventional Radiology. 3rd ed. Philadelphia, PA: Lippincott Williams & Wilkins; 2014: 239-245
• 88 Rutgers JL, Spong CY, Sinow R, Heiner J. Leuprolide acetate treatment and myoma arterial size. Obstet Gynecol 1995; 86 (03) 386-388
• 89 Chen I, Motan T, Kiddoo D. Gonadotropin-releasing hormone agonist in laparoscopic myomectomy: systematic review and meta-analysis of randomized controlled trials. J Minim Invasive Gynecol 2011; 18 (03) 303-309
• 90 Palomba S, Pellicano M, Affinito P, Di Carlo C, Zullo F, Nappi C. Effectiveness of short-term administration of tibolone plus gonadotropin-releasing hormone analogue on the surgical outcome of laparoscopic myomectomy. Fertil Steril 2001; 75 (02) 429-433
• 91 Donnez J, Tomaszewski J, Vázquez F. , et al; PEARL II Study Group. Ulipristal acetate versus leuprolide acetate for uterine fibroids. N Engl J Med 2012; 366 (05) 421-432
• 92 Leone Roberti Maggiore U, Scala C, Venturini PL, Ferrero S. Preoperative treatment with letrozole in patients undergoing laparoscopic myomectomy of large uterine myomas: a prospective non-randomized study. Eur J Obstet Gynecol Reprod Biol 2014; 181: 157-162
• 93 Masciocchi C, Arrigoni F, Ferrari F. , et al. Uterine fibroid therapy using interventional radiology mini-invasive treatments: current perspective. Med Oncol 2017; 34 (04) 52-017
• 94 Holub Z, Mara M, Kuzel D, Jabor A, Maskova J, Eim J. Pregnancy outcomes after uterine artery occlusion: prospective multicentric study. Fertil Steril 2008; 90 (05) 1886-1891
• 95 Goldman KN, Hirshfeld-Cytron JE, Pavone ME, Thomas AP, Vogelzang RL, Milad MP. Uterine artery embolization immediately preceding laparoscopic myomectomy. Int J Gynaecol Obstet 2012; 116 (02) 105-108
• 96 Silberzweig JE, Powell DK, Matsumoto AH, Spies JB. Management of uterine fibroids: a focus on uterine-sparing interventional techniques. Radiology 2016; 280 (03) 675-692
• 97 Spies JB. Current role of uterine artery embolization in the management of uterine fibroids. Clin Obstet Gynecol 2016; 59 (01) 93-102
• 98 Mara M, Maskova J, Fucikova Z, Kuzel D, Belsan T, Sosna O. Midterm clinical and first reproductive results of a randomized controlled trial comparing uterine fibroid embolization and myomectomy. Cardiovasc Intervent Radiol 2008; 31 (01) 73-85
• 99 Hovsepian DM, Siskin GP, Bonn J. , et al; CIRSE and SIR Standards of Practice Committees. Quality improvement guidelines for uterine artery embolization for symptomatic leiomyomata. J Vasc Interv Radiol 2009; 20 (7, Suppl): S193-S199
• 100 Worthington-Kirsch RL. Uterine artery embolization: state of the art. Semin Intervent Radiol 2004; 21 (01) 37-42
• 101 Pron G, Mocarski E, Bennett J, Vilos G, Common A, Vanderburgh L. ; Ontario UFE Collaborative Group. Pregnancy after uterine artery embolization for leiomyomata: the Ontario multicenter trial. Obstet Gynecol 2005; 105 (01) 67-76
• 102 Dutton S, Hirst A, McPherson K, Nicholson T, Maresh M. A UK multicentre retrospective cohort study comparing hysterectomy and uterine artery embolisation for the treatment of symptomatic uterine fibroids (HOPEFUL study): main results on medium-term safety and efficacy. BJOG 2007; 114 (11) 1340-1351
• 103 Song T, Kim TJ, Lee SH, Kim TH, Kim WY. Laparoendoscopic single-site myomectomy compared with conventional laparoscopic myomectomy: a multicenter, randomized, controlled trial. Fertil Steril 2015; 104 (05) 1325-1331
• 104 Litta P, Fantinato S, Calonaci F. , et al. A randomized controlled study comparing harmonic versus electrosurgery in laparoscopic myomectomy. Fertil Steril 2010; 94 (05) 1882-1886
• 105 Su H, Han CM, Wang CJ, Lee CL, Soong YK. Comparison of the efficacy of the pulsed bipolar system and conventional electrosurgery in laparoscopic myomectomy - a retrospective matched control study. Taiwan J Obstet Gynecol 2011; 50 (01) 25-28
• 106 Song T, Kim TJ, Kim WY, Lee SH. Comparison of barbed suture versus traditional suture in laparoendoscopic single-site myomectomy. Eur J Obstet Gynecol Reprod Biol 2015; 185: 99-102
• 107 Tulandi T, Einarsson JI. The use of barbed suture for laparoscopic hysterectomy and myomectomy: a systematic review and meta-analysis. J Minim Invasive Gynecol 2014; 21 (02) 210-216
• 108 Alessandri F, Remorgida V, Venturini PL, Ferrero S. Unidirectional barbed suture versus continuous suture with intracorporeal knots in laparoscopic myomectomy: a randomized study. J Minim Invasive Gynecol 2010; 17 (06) 725-729
• 109 Adelman MR. The morcellation debate: the history and the science. Clin Obstet Gynecol 2015; 58 (04) 710-717
• 110 U.S. Food and Drug Administration. Laparoscopic uterine power morcellation in hysterectomy and myomectomy: FDA safety communication. U.S. Department of Health and Human Services Web site. https://www.fda.gov/MedicalDevices/Safety/AlertsandNotices/ucm393576.htm . Published November 24, 2014 . Updated 2014. Accessed April 2017
• 111 Levitz J. Doctors eye cancer risk in uterine procedure. The Wall Street Journal. December 18, 2013 ; U.S. News. Available at: https://www.wsj.com/articles/doctors-eye-cancer-risk-in-uterine-procedure-1387328455?tesla=y . Accessed September 26, 2017
• 112 Steiner RA, Wight E, Tadir Y, Haller U. Electrical cutting device for laparoscopic removal of tissue from the abdominal cavity. Obstet Gynecol 1993; 81 (03) 471-474
• 113 Park JY, Park SK, Kim DY. , et al. The impact of tumor morcellation during surgery on the prognosis of patients with apparently early uterine leiomyosarcoma. Gynecol Oncol 2011; 122 (02) 255-259
• 114 Seidman MA, Oduyebo T, Muto MG, Crum CP, Nucci MR, Quade BJ. Peritoneal dissemination complicating morcellation of uterine mesenchymal neoplasms. PLoS One 2012; 7 (11) e50058
• 115 Oduyebo T, Rauh-Hain AJ, Meserve EE. , et al. The value of re-exploration in patients with inadvertently morcellated uterine sarcoma. Gynecol Oncol 2014; 132 (02) 360-365
• 116 George S, Barysauskas C, Serrano C. , et al. Retrospective cohort study evaluating the impact of intraperitoneal morcellation on outcomes of localized uterine leiomyosarcoma. Cancer 2014; 120 (20) 3154-3158
• 117 U.S. Food and Drug Administration. Quantitative assessment of the prevalence of unsuspected uterine sarcoma in women undergoing treatment of uterine fibroids. summary and key findings. FDA Safety Communications 2014; 213: e1-e6
• 118 Lieng M, Berner E, Busund B. Risk of morcellation of uterine leiomyosarcomas in laparoscopic supracervical hysterectomy and laparoscopic myomectomy, a retrospective trial including 4791 women. J Minim Invasive Gynecol 2015; 22 (03) 410-414
• 119 Wright JD, Tergas AI, Burke WM. , et al. Uterine pathology in women undergoing minimally invasive hysterectomy using morcellation. JAMA 2014; 312 (12) 1253-1255
• 120 Tan-Kim J, Hartzell KA, Reinsch CS. , et al. Uterine sarcomas and parasitic myomas after laparoscopic hysterectomy with power morcellation. Am J Obstet Gynecol 2015; 212 (05) 594.e1-594.e10
• 121 Goff BA. SGO not soft on morcellation: risks and benefits must be weighed. Lancet Oncol 2014; 15 (04) e148-e2045
• 122 AAGL Advancing Minimally Invasive Gynecology Worldwide. AAGL practice report: morcellation during uterine tissue extraction. J Minim Invasive Gynecol 2014; 21 (04) 517-530
• 123 American College of Obstetricians and Gynecologists. Power morcellation and occult malignancy in gynecologic surgery. American College of Obstetricians and Gynecologists: Task Force and Work Group Reports, Executive Summary. 2014; May: 1–6.
• 124 Kho KA, Brown DN. Surgical treatment of uterine fibroids within a containment system and without power morcellation. Clin Obstet Gynecol 2016; 59 (01) 85-92
• 125 Desai VB, Guo XM, Xu X. Alterations in surgical technique after FDA statement on power morcellation. Am J Obstet Gynecol 2015; 212 (05) 685-687
• 126 Truong MD, Advincula AP. The extracorporeal C-incision tissue extraction (ExCITE) technique. OBG Management 2014; 26 (11) 56
• 127 Srouji SS, Kaser DJ, Gargiulo AR. Techniques for contained morcellation in gynecologic surgery. Fertil Steril 2015; 103 (04) e34
• 128 Rimbach S, Holzknecht A, Nemes C, Offner F, Craina M. A new in-bag system to reduce the risk of tissue morcellation: development and experimental evaluation during laparoscopic hysterectomy. Arch Gynecol Obstet 2015; 292 (06) 1311-1320
• 129 Kongnyuy EJ, van den Broek N, Wiysonge CS. A systematic review of randomized controlled trials to reduce hemorrhage during myomectomy for uterine fibroids. Int J Gynaecol Obstet 2008; 100 (01) 4-9
• 130 Hickman LC, Kotlyar A, Shue S, Falcone T. Hemostatic techniques for myomectomy: an evidence-based approach. J Minim Invasive Gynecol 2016; 23 (04) 497-504
• 131 Song T, Kim MK, Kim ML, Jung YW, Yun BS, Seong SJ. Use of vasopressin vs epinephrine to reduce haemorrhage during myomectomy: a randomized controlled trial. Eur J Obstet Gynecol Reprod Biol 2015; 195: 177-181
• 132 Liu L, Li Y, Xu H, Chen Y, Zhang G, Liang Z. Laparoscopic transient uterine artery occlusion and myomectomy for symptomatic uterine myoma. Fertil Steril 2011; 95 (01) 254-258
• 133 Vercellino G, Erdemoglu E, Joe A. , et al. Laparoscopic temporary clipping of uterine artery during laparoscopic myomectomy. Arch Gynecol Obstet 2012; 286 (05) 1181-1186
• 134 Alborzi S, Ghannadan E, Alborzi S, Alborzi M. A comparison of combined laparoscopic uterine artery ligation and myomectomy versus laparoscopic myomectomy in treatment of symptomatic myoma. Fertil Steril 2009; 92 (02) 742-747
• 135 Kwon YS, Roh HJ, Ahn JW, Lee SH, Im KS. Transient occlusion of uterine arteries in laparoscopic uterine surgery. JSLS 2015; 19 (01) 00189
• 136 Kwon YS, Jung DY, Lee SH, Ahn JW, Roh HJ, Im KS. Transient occlusion of uterine arteries with endoscopic vascular clip preceding laparoscopic myomectomy. J Laparoendosc Adv Surg Tech A 2013; 23 (08) 679-683
• 137 Dubuisson JB, Fauconnier A, Chapron C, Kreiker G, Nörgaard C. Second look after laparoscopic myomectomy. Hum Reprod 1998; 13 (08) 2102-2106
• 138 Tinelli A, Malvasi A, Guido M. , et al. Adhesion formation after intracapsular myomectomy with or without adhesion barrier. Fertil Steril 2011; 95 (05) 1780-1785
• 139 Mais V, Ajossa S, Piras B, Guerriero S, Marongiu D, Melis GB. Prevention of de-novo adhesion formation after laparoscopic myomectomy: a randomized trial to evaluate the effectiveness of an oxidized regenerated cellulose absorbable barrier. Hum Reprod 1995; 10 (12) 3133-3135
• 140 Fossum GT, Silverberg KM, Miller CE, Diamond MP, Holmdahl L. Gynecologic use of Sepraspray Adhesion Barrier for reduction of adhesion development after laparoscopic myomectomy: a pilot study. Fertil Steril 2011; 96 (02) 487-491
• 141 Tchartchian G, Hackethal A, Herrmann A. , et al. Evaluation of SprayShield™ Adhesion Barrier in a single center: randomized controlled study in 15 women undergoing reconstructive surgery after laparoscopic myomectomy. Arch Gynecol Obstet 2014; 290 (04) 697-704
• 142 Mettler L, Hucke J, Bojahr B, Tinneberg HR, Leyland N, Avelar R. A safety and efficacy study of a resorbable hydrogel for reduction of post-operative adhesions following myomectomy. Hum Reprod 2008; 23 (05) 1093-1100
• 143 Pellicano M, Bramante S, Cirillo D. , et al. Effectiveness of autocrosslinked hyaluronic acid gel after laparoscopic myomectomy in infertile patients: a prospective, randomized, controlled study. Fertil Steril 2003; 80 (02) 441-444
• 144 Ahmad G, O'Flynn H, Hindocha A, Watson A. Barrier agents for adhesion prevention after gynaecological surgery. Cochrane Database Syst Rev 2015; (04) CD000475
• 145 Bhave Chittawar P, Franik S, Pouwer AW, Farquhar C. Minimally invasive surgical techniques versus open myomectomy for uterine fibroids. Cochrane Database Syst Rev 2014; (10) CD004638
• 146 Lee HJ, Kim JY, Kim SK, Lee JR, Suh CS, Kim SH. Learning curve analysis and surgical outcomes of single-port laparoscopic myomectomy. J Minim Invasive Gynecol 2015; 22 (04) 607-611
• 147 Radosa MP, Owsianowski Z, Mothes A. , et al. Long-term risk of fibroid recurrence after laparoscopic myomectomy. Eur J Obstet Gynecol Reprod Biol 2014; 180: 35-39
• 148 Doridot V, Dubuisson JB, Chapron C, Fauconnier A, Babaki-Fard K. Recurrence of leiomyomata after laparoscopic myomectomy. J Am Assoc Gynecol Laparosc 2001; 8 (04) 495-500
• 149 Nezhat FR, Roemisch M, Nezhat CH, Seidman DS, Nezhat CR. Recurrence rate after laparoscopic myomectomy. J Am Assoc Gynecol Laparosc 1998; 5 (03) 237-240
• 150 Flyckt R, Soto E, Nutter B, Falcone T. Comparison of long-term fertility and bleeding outcomes after robotic-assisted, laparoscopic, and abdominal myomectomy. Obstet Gynecol Int 2016; 2016: 2789201
• 151 Bernardi TS, Radosa MP, Weisheit A. , et al. Laparoscopic myomectomy: a 6-year follow-up single-center cohort analysis of fertility and obstetric outcome measures. Arch Gynecol Obstet 2014; 290 (01) 87-91
• 152 Metwally M, Cheong YC, Horne AW. Surgical treatment of fibroids for subfertility. Cochrane Database Syst Rev 2012; 11: CD003857
• 153 Koo YJ, Lee JK, Lee YK. , et al. Pregnancy outcomes and risk factors for uterine rupture after laparoscopic myomectomy: a single-center experience and literature review. J Minim Invasive Gynecol 2015; 22 (06) 1022-1028
• 154 Parker WH, Einarsson J, Istre O, Dubuisson JB. Risk factors for uterine rupture after laparoscopic myomectomy. J Minim Invasive Gynecol 2010; 17 (05) 551-554
• 155 Gambacorti-Passerini Z, Gimovsky AC, Locatelli A, Berghella V. Trial of labor after myomectomy and uterine rupture: a systematic review. Acta Obstet Gynecol Scand 2016; 95 (07) 724-734
• 156 Claeys J, Hellendoom I, Hamerlynch T, Bosteels J, Weters S. The risk of uterine rupture after myomectomy: a systematic review of the literature and meta-analysis. Gynecol Surg 2014; 1 (197) 197-206
• 157 Alessandri F, Lijoi D, Mistrangelo E, Ferrero S, Ragni N. Randomized study of laparoscopic versus minilaparotomic myomectomy for uterine myomas. J Minim Invasive Gynecol 2006; 13 (02) 92-97
• 158 American College of Obstetricians and Gynecologists. ACOG practice bulletin. Alternatives to hysterectomy in the management of leiomyomas. Obstet Gynecol 2008; 112 (2, Pt 1): 387-400
• 159 Gargiulo AR, Lewis EI, Kaser DJ, Srouji SS. Robotic single-site myomectomy: a step-by-step tutorial. J Minim Invasive Gynecol 2015; 22 (6S): S135
• 160 Iavazzo C, Mamais I, Gkegkes ID. Robotic assisted vs laparoscopic and/or open myomectomy: systematic review and meta-analysis of the clinical evidence. Arch Gynecol Obstet 2016; 294 (01) 5-17
• 161 Lim PC, Kang E, Park DH. Learning curve and surgical outcome for robotic-assisted hysterectomy with lymphadenectomy: case-matched controlled comparison with laparoscopy and laparotomy for treatment of endometrial cancer. J Minim Invasive Gynecol 2010; 17 (06) 739-748
• 162 Lenihan Jr JP, Kovanda C, Seshadri-Kreaden U. What is the learning curve for robotic assisted gynecologic surgery?. J Minim Invasive Gynecol 2008; 15 (05) 589-594
• 163 Advincula AP, Xu X, Goudeau IV S, Ransom SB. Robot-assisted laparoscopic myomectomy versus abdominal myomectomy: a comparison of short-term surgical outcomes and immediate costs. J Minim Invasive Gynecol 2007; 14 (06) 698-705
• 164 Bedient CE, Magrina JF, Noble BN, Kho RM. Comparison of robotic and laparoscopic myomectomy. Am J Obstet Gynecol 2009; 201 (06) 566.e1-566.e5
• 165 Nezhat C, Lavie O, Hsu S, Watson J, Barnett O, Lemyre M. Robotic-assisted laparoscopic myomectomy compared with standard laparoscopic myomectomy--a retrospective matched control study. Fertil Steril 2009; 91 (02) 556-559
• 166 Göçmen A, Şanlıkan F, Uçar MG. Comparison of robotic-assisted laparoscopic myomectomy outcomes with laparoscopic myomectomy. Arch Gynecol Obstet 2013; 287 (01) 91-96
• 167 Pundir J, Pundir V, Walavalkar R, Omanwa K, Lancaster G, Kayani S. Robotic-assisted laparoscopic vs abdominal and laparoscopic myomectomy: systematic review and meta-analysis. J Minim Invasive Gynecol 2013; 20 (03) 335-345
• 168 Barakat EE, Bedaiwy MA, Zimberg S, Nutter B, Nosseir M, Falcone T. Robotic-assisted, laparoscopic, and abdominal myomectomy: a comparison of surgical outcomes. Obstet Gynecol 2011; 117 (2, Pt 1): 256-265
• 169 Hsiao SM, Lin HH, Peng FS, Jen PJ, Hsiao CF, Tu FC. Comparison of robot-assisted laparoscopic myomectomy and traditional laparoscopic myomectomy. J Obstet Gynaecol Res 2013; 39 (05) 1024-1029
• 170 Pitter MC, Gargiulo AR, Bonaventura LM, Lehman JS, Srouji SS. Pregnancy outcomes following robot-assisted myomectomy. Hum Reprod 2013; 28 (01) 99-108
• 171 Saito A, Hirata T, Koga K. , et al. Preoperative assessment of factors associated with difficulty in performing total laparoscopic hysterectomy. J Obstet Gynaecol Res 2017; 43 (02) 320-329
• 172 David-Montefiore E, Rouzier R, Chapron C, Daraï E. ; Collegiale d'Obstétrique et Gynécologie de Paris-Ile de France. Surgical routes and complications of hysterectomy for benign disorders: a prospective observational study in French university hospitals. Hum Reprod 2007; 22 (01) 260-265
• 173 Guo Y, Tian X, Wang L. Laparoscopically assisted vaginal hysterectomy vs vaginal hysterectomy: meta analysis. J Minim Invasive Gynecol 2013; 20 (01) 15-21
• 174 Seracchioli R, Venturoli S, Colombo FM. , et al. GnRH agonist treatment before total laparoscopic hysterectomy for large uteri. J Am Assoc Gynecol Laparosc 2003; 10 (03) 316-319
• 175 Chang FW, Yu MH, Ku CH, Chen CH, Wu GJ, Liu JY. Effect of uterotonics on intra-operative blood loss during laparoscopy-assisted vaginal hysterectomy: a randomised controlled trial. BJOG 2006; 113 (01) 47-52
• 176 Rothmund R, Kraemer B, Brucker S. , et al. Laparoscopic supracervical hysterectomy using EnSeal vs standard bipolar coagulation technique: randomized controlled trial. J Minim Invasive Gynecol 2013; 20 (05) 661-666
• 177 Janssen PF, Brölmann HA, van Kesteren PJ. , et al. Perioperative outcomes using LigaSure compared with conventional bipolar instruments in laparoscopic hysterectomy: a randomised controlled trial. BJOG 2011; 118 (13) 1568-1575
• 178 Rothmund R, Szyrach M, Reda A. , et al. A prospective, randomized clinical comparison between UltraCision and the novel sealing and cutting device BiCision in patients with laparoscopic supracervical hysterectomy. Surg Endosc 2013; 27 (10) 3852-3859
• 179 Aytan H, Nazik H, Narin R, Api M, Tok EC. Comparison of the use of LigaSure, HALO PKS cutting forceps, and ENSEAL tissue sealer in total laparoscopic hysterectomy: a randomized trial. J Minim Invasive Gynecol 2014; 21 (04) 650-655
• 180 Janssen PF, Brölmann HA, Huirne JA. Recommendations to prevent urinary tract injuries during laparoscopic hysterectomy: a systematic Delphi procedure among experts. J Minim Invasive Gynecol 2011; 18 (03) 314-321
• 181 van den Haak L, Alleblas C, Nieboer TE, Rhemrev JP, Jansen FW. Efficacy and safety of uterine manipulators in laparoscopic surgery: a review. Arch Gynecol Obstet 2015; 292 (05) 1003-1011
• 182 Uccella S, Ceccaroni M, Cromi A. , et al. Vaginal cuff dehiscence in a series of 12,398 hysterectomies: effect of different types of colpotomy and vaginal closure. Obstet Gynecol 2012; 120 (03) 516-523
• 183 Siedhoff MT, Kim KH. Morcellation and myomas: balancing decisions around minimally invasive treatments for fibroids. J Surg Oncol 2015; 112 (07) 769-771
• 184 Hur HC, King LP, Klebanoff MJ, Hur C, Ricciotti HA. Fibroid morcellation: a shared clinical decision tool for mode of hysterectomy. Eur J Obstet Gynecol Reprod Biol 2015; 195: 122-127
• 185 Aarts JW, Nieboer TE, Johnson N. , et al. Surgical approach to hysterectomy for benign gynaecological disease. Cochrane Database Syst Rev 2015; (08) CD003677
• 186 Walsh CA, Walsh SR, Tang TY, Slack M. Total abdominal hysterectomy versus total laparoscopic hysterectomy for benign disease: a meta-analysis. Eur J Obstet Gynecol Reprod Biol 2009; 144 (01) 3-7
• 187 Gendy R, Walsh CA, Walsh SR, Karantanis E. Vaginal hysterectomy versus total laparoscopic hysterectomy for benign disease: a metaanalysis of randomized controlled trials. Am J Obstet Gynecol 2011; 204 (05) 388.e1-388.e8
• 188 Lethaby A, Mukhopadhyay A, Naik R. Total versus subtotal hysterectomy for benign gynaecological conditions. Cochrane Database Syst Rev 2012; (04) CD004993
• 189 AAGL Advancing Minimally Invasive Gynecology Worldwide. AAGL position statement: robotic-assisted laparoscopic surgery in benign gynecology. J Minim Invasive Gynecol 2013; 20 (01) 2-9
• 190 Chudnoff SG, Berman JM, Levine DJ, Harris M, Guido RS, Banks E. Outpatient procedure for the treatment and relief of symptomatic uterine myomas. Obstet Gynecol 2013; 121 (05) 1075-1082
• 191 Berman JM, Guido RS, Garza Leal JG, Pemueller RR, Whaley FS, Chudnoff SG. ; Halt Study Group. Three-year outcome of the Halt trial: a prospective analysis of radiofrequency volumetric thermal ablation of myomas. J Minim Invasive Gynecol 2014; 21 (05) 767-774
• 192 Brucker SY, Hahn M, Kraemer D, Taran FA, Isaacson KB, Krämer B. Laparoscopic radiofrequency volumetric thermal ablation of fibroids versus laparoscopic myomectomy. Int J Gynaecol Obstet 2014; 125 (03) 261-265
• 193 Hahn M, Brucker S, Kraemer D. , et al. Radiofrequency volumetric thermal ablation of fibroids and laparoscopic myomectomy: long-term follow-up from a randomized trial. Geburtshilfe Frauenheilkd 2015; 75 (05) 442-449
• 194 Krämer B, Hahn M, Taran FA, Kraemer D, Isaacson KB, Brucker SY. Interim analysis of a randomized controlled trial comparing laparoscopic radiofrequency volumetric thermal ablation of uterine fibroids with laparoscopic myomectomy. Int J Gynaecol Obstet 2016; 133 (02) 206-211
• 195 Toub DB. A new paradigm for uterine fibroid treatment: transcervical, intrauterine sonography-guided radiofrequency ablation of uterine fibroids with the sonata system. Curr Obstet Gynecol Rep 2017; 6 (01) 67-73
• 196 Garza-Leal JG, Toub DB, Leon IH. , et al. Transcervical, intrauterine ultrasound-guided radiofrequency ablation of uterine fibroids with the VizAblate system: Safety, tolerability, and ablation results in a closed abdomen setting. Gynecol Surg 2011; 8 (03) 327-334
• 197 Brölmann H, Bongers M, Garza-Leal JG. , et al. The FAST-EU trial: 12-month clinical outcomes of women after intrauterine sonography-guided transcervical radiofrequency ablation of uterine fibroids. Gynecol Surg 2016; 13: 27-35
• 198 Garza-Leal JG, Leon IH, Toub D. Pregnancy after transcervical radiofrequency ablation guided by intrauterine sonography: case report. Gynecol Surg 2014; 11 (02) 145-149
• 199 Berman JM, Bolnick JM, Pemueller RR, Garza Leal JG. Reproductive outcomes in women following radiofrequency volumetric thermal ablation of symptomatic fibroids. A retrospective case series analysis. J Reprod Med 2015; 60 (5-6): 194-198